Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived Conditions

Oligodendrocytes are supporting glial cells that ensure the metabolism and homeostasis of neurons with specific synaptic axoglial interactions in the central nervous system. These require key myelinating glial trophic signals important for growth and metabolism. Thyroid hormone (TH) is one such trop...

Full description

Bibliographic Details
Main Authors: Min Joung Kim, Steven Petratos
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2019/5496891
id doaj-389f8d369e3a4fabba49bdbabf7e8cb6
record_format Article
spelling doaj-389f8d369e3a4fabba49bdbabf7e8cb62020-11-25T02:34:10ZengHindawi LimitedStem Cells International1687-966X1687-96782019-01-01201910.1155/2019/54968915496891Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived ConditionsMin Joung Kim0Steven Petratos1Department of Neuroscience, Central Clinical School, Monash University, Prahran, Victoria 3004, AustraliaDepartment of Neuroscience, Central Clinical School, Monash University, Prahran, Victoria 3004, AustraliaOligodendrocytes are supporting glial cells that ensure the metabolism and homeostasis of neurons with specific synaptic axoglial interactions in the central nervous system. These require key myelinating glial trophic signals important for growth and metabolism. Thyroid hormone (TH) is one such trophic signal that regulates oligodendrocyte maturation, myelination, and oligodendroglial synaptic dynamics via either genomic or nongenomic pathways. The intracellular and extracellular transport of TH is facilitated by a specific transmembrane transporter known as the monocarboxylate transporter 8 (MCT8). Dysfunction of the MCT8 due to mutation, inhibition, or downregulation during brain development leads to inherited hypomyelination, which manifests as psychomotor retardation in the X-linked inherited Allan-Herndon-Dudley syndrome (AHDS). In particular, oligodendroglial-specific MCT8 deficiency may restrict the intracellular T3 availability, culminating in deficient metabolic communication between the oligodendrocytes and the neurons they ensheath, potentially promulgating neurodegenerative adult diseases such as multiple sclerosis (MS). Based on the therapeutic effects exhibited by TH in various preclinical studies, particularly related to its remyelinating potential, TH has now entered the initial stages of a clinical trial to test the therapeutic efficacy in relapsing-remitting MS patients (NCT02506751). However, TH analogs, such as DITPA or Triac, may well serve as future therapeutic options to rescue mature oligodendrocytes and/or promote oligodendrocyte precursor cell differentiation in an environment of MCT8 deficiency within the CNS. This review outlines the therapeutic strategies to overcome the differentiation blockade of oligodendrocyte precursors and maintain mature axoglial interactions in TH-deprived conditions.http://dx.doi.org/10.1155/2019/5496891
collection DOAJ
language English
format Article
sources DOAJ
author Min Joung Kim
Steven Petratos
spellingShingle Min Joung Kim
Steven Petratos
Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived Conditions
Stem Cells International
author_facet Min Joung Kim
Steven Petratos
author_sort Min Joung Kim
title Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived Conditions
title_short Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived Conditions
title_full Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived Conditions
title_fullStr Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived Conditions
title_full_unstemmed Oligodendroglial Lineage Cells in Thyroid Hormone-Deprived Conditions
title_sort oligodendroglial lineage cells in thyroid hormone-deprived conditions
publisher Hindawi Limited
series Stem Cells International
issn 1687-966X
1687-9678
publishDate 2019-01-01
description Oligodendrocytes are supporting glial cells that ensure the metabolism and homeostasis of neurons with specific synaptic axoglial interactions in the central nervous system. These require key myelinating glial trophic signals important for growth and metabolism. Thyroid hormone (TH) is one such trophic signal that regulates oligodendrocyte maturation, myelination, and oligodendroglial synaptic dynamics via either genomic or nongenomic pathways. The intracellular and extracellular transport of TH is facilitated by a specific transmembrane transporter known as the monocarboxylate transporter 8 (MCT8). Dysfunction of the MCT8 due to mutation, inhibition, or downregulation during brain development leads to inherited hypomyelination, which manifests as psychomotor retardation in the X-linked inherited Allan-Herndon-Dudley syndrome (AHDS). In particular, oligodendroglial-specific MCT8 deficiency may restrict the intracellular T3 availability, culminating in deficient metabolic communication between the oligodendrocytes and the neurons they ensheath, potentially promulgating neurodegenerative adult diseases such as multiple sclerosis (MS). Based on the therapeutic effects exhibited by TH in various preclinical studies, particularly related to its remyelinating potential, TH has now entered the initial stages of a clinical trial to test the therapeutic efficacy in relapsing-remitting MS patients (NCT02506751). However, TH analogs, such as DITPA or Triac, may well serve as future therapeutic options to rescue mature oligodendrocytes and/or promote oligodendrocyte precursor cell differentiation in an environment of MCT8 deficiency within the CNS. This review outlines the therapeutic strategies to overcome the differentiation blockade of oligodendrocyte precursors and maintain mature axoglial interactions in TH-deprived conditions.
url http://dx.doi.org/10.1155/2019/5496891
work_keys_str_mv AT minjoungkim oligodendrogliallineagecellsinthyroidhormonedeprivedconditions
AT stevenpetratos oligodendrogliallineagecellsinthyroidhormonedeprivedconditions
_version_ 1724809841013161984